Results 151 to 160 of about 58,085 (295)

DPP4 in diabetes [PDF]

, 2015
Diana Röhrborn
core   +1 more source

Identification of subgroups of patients with type 2 diabetes with differences in renal function preservation, comparing patients receiving sodium‐glucose co‐transporter‐2 inhibitors with those receiving dipeptidyl peptidase‐4 inhibitors, using a supervised machine‐learning algorithm (PROFILE study): A retrospective analysis of a Japanese commercial medical database

, 2019
Fang Liz Zhou, Hirotaka Watada, Yuki Tajima, Mathilde Berthelot, Dian Kang, C. Esnault, Yujin Shuto, Hiroshi Maegawa, Daisuke Koya   +8 more
openalex   +1 more source

The risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors

, 2020
Ann Wan-Chin Ling, Cze-Ci Chan, Shao‐Wei Chen, Wei-Yi Kao, Chien-Ying Huang, Yi‐Hsin Chan, Pao-Hsien Chu   +6 more
openalex   +1 more source

The effect of dipeptidyl peptidase-4 inhibitor on incidence and clinical course in bullous pemphigoid patients in a tertiary medical center. [PDF]

Kaohsiung J Med Sci, 2023
Hsu YA, Yang TT, Huang SM, Lan CE.
europepmc   +1 more source

AB1166 The association of the early onset of remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome with dipeptidyl peptidase-4 (DPP4) inhibitor [PDF]

, 2018
Yuji Yoshioka, Masato Mitsuhashi, Amami Kato, Daisuke Kanai, Arnold J. Suda, S. Nagaoka   +5 more
openalex   +1 more source

Linagliptin: from bench to bedside

Drug Design, Development and Therapy, 2014
John DoupisIatriko Palaiou Falirou Medical Center, Division of Diabetes, Athens, GreecePurpose: The nature of biomedical research affords a broad range of investigational topics at the preclinical stage, not all of which may be explored in subsequent ...
Doupis J
doaj  

Dipeptidyl peptidase-4 and kidney fibrosis in diabetes [PDF]

, 2016
Daisuke Koya, Keizo Kanasaki, Sen Shi
core   +1 more source

Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort study [PDF]

, 2023
Richeek Pradhan, Oriana Hoi Yun Yu, Robert W. Platt, Laurent Azoulay   +3 more
openalex   +1 more source

Review for "Use of dipeptidyl peptidase 4 inhibitors and risk of splanchnic vein thrombosis: A Danish nationwide new user active comparator cohort study"

, 2020
Michael Adena
openalex   +1 more source

Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment

Diabetes, Metabolic Syndrome and Obesity, 2013
David ScottClinical Research Development Associates, Rosedale, NY, USAAbstract: Diabetes is the leading cause of chronic kidney disease, and the prevalence of both diseases is rising worldwide.
Scott D
doaj